An in-depth look to PHARMOCANN GLOBAL operating, investing, and financing activities

PMCN-M free cash flow for H1 24 is -852 k ILS. For 2023, PMCN-M free cash flow was -4.91 M ILS and operating cash flow was -4.88 M ILS.